Skip to the page

Data / Form D filings / AFFINIMARK TECHNOLOGIES INC

AFFINIMARK TECHNOLOGIES INC: Form D filings

AFFINIMARK TECHNOLOGIES INC, a pharmaceuticals company in New Haven, CT, filed 3 Form D notices with the SEC between 2010 and 2016. The latest, on March 3, 2016, reports $1.6 million sold of a $1.6 million offering to 1 investor.

Find out what AFFINIMARK TECHNOLOGIES INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
300 GEORGE STREET, SUITE 561, New Haven, CT, 06511
Phone
(203) 676-3676
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1429101

The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 3, 2016Amendment$1,550,000$1,550,000$01Feb 12, 2016sec.gov
Mar 3, 2016New notice$1,550,000$1,550,000$01Feb 12, 2016sec.gov
Oct 8, 2010New notice$1,359,394$821,894$537,5008Sep 27, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
VINCENT H. PIERIBONEExecutive Officer, Director
KEVIN CROWLEYDirector
HARRY H. PENNER, JR.Executive Officer, Director
KONSTANTINE H. DRAKONAKISDirector

Other pharmaceuticals companies in Connecticut that filed recently

Every Form D from the week of Feb 29, 2016 · All recent filings in Connecticut · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what AFFINIMARK TECHNOLOGIES INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.